Population Based Germline Testing for Early Detection and Prevention of Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Population Based Germline Testing for Early Detection and Prevention of Cancer — Stella

Recruiting

Back to Breast Cancer Risk trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

Wolfson Institute of Population Health, Queen Mary University of London, London

Key details

Sponsor

Queen Mary University of London

Collaborators

University of Cambridge, University of Manchester

Enrollment target

~6,000 participants

Started

December 2025

Primary completion

December 2029

Age range

18 Years and older

Sex

Female only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov